Education
About Us
Working with TipRanks
Follow Us
ATAI Life Sciences (ATAI)
NASDAQ:ATAI
Total Valuation
ATAI Life Sciences has a market cap or net worth of $299.69M. The enterprise value is $109.80M.
Market Cap$299.69M
Enterprise Value$109.80M
Share Statistics
ATAI Life Sciences has 199,795,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding199,795,030
Owned by Insiders33.75%
Owned by Institutions0.05%
Financial Efficiency
ATAI Life Sciences’s return on equity (ROE) is -1.28 and return on invested capital (ROIC) is -72.86%.
Return on Equity (ROE)-1.28
Return on Assets (ROA)-0.94
Return on Invested Capital (ROIC)-72.86%
Return on Capital Employed (ROCE)-0.76
Revenue Per Employee0.00
Profits Per Employee-2.78M
Employee Count54
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ATAI Life Sciences is -1.43. ATAI Life Sciences’s PEG ratio is >-0.01.
PE Ratio-1.43
PS Ratio0.00
PB Ratio1.83
Price to Fair Value1.83
Price to FCF-2.58
Price to Operating Cash Flow-2.58
PEG Ratio>-0.01
Income Statement
In the last 12 months, ATAI Life Sciences had revenue of 0.00 and earned -149.27M in profits. Earnings per share was -0.93.
Revenue0.00
Gross Profit0.00
Operating Income-102.69M
Pretax Income-148.41M
Net Income-149.27M
EBITDA-102.69M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -79.24M and capital expenditures -11.04K, giving a free cash flow of -56.68M billion.
Operating Cash Flow-79.24M
Free Cash Flow-56.68M
Free Cash Flow per Share-0.28
Dividends & Yields
ATAI Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.59
52-Week Price Change-30.85%
50-Day Moving Average1.45
200-Day Moving Average1.44
Relative Strength Index (RSI)46.41
Average Volume (3m)1.65M
Important Dates
ATAI Life Sciences upcoming earnings date is May 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
ATAI Life Sciences as a current ratio of 3.21, with Debt / Equity ratio of 16.34%
Current Ratio3.21
Quick Ratio3.21
Debt to Market Cap0.04
Net Debt to EBITDA0.10
Interest Coverage Ratio32.87
Taxes
In the past 12 months, ATAI Life Sciences has paid 356.00K in taxes.
Income Tax356.00K
Effective Tax Rate>-0.01
Enterprise Valuation
ATAI Life Sciences EV to EBITDA ratio is -1.98, with an EV/FCF ratio of -2.46.
EV to Sales0.00
EV to EBITDA-1.98
EV to Free Cash Flow-2.46
EV to Operating Cash Flow-2.46
Balance Sheet
ATAI Life Sciences has $44.96M in cash and marketable securities with ― in debt, giving a net cash position of -$21.16M billion.
Cash & Marketable Securities$44.96M
Total Debt―
Net Cash-$21.16M
Net Cash Per Share-$0.11
Tangible Book Value Per Share$0.71
Margins
Gross margin is 19.64%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin19.64%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for ATAI Life Sciences is $8.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.00
Price Target Upside479.71% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast-0.90%
EPS Growth Forecast-89.51%